Skip to search boxSkip to navigationSkip to main content

Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia

  • Charles H. Adler(corresponding author)
    ,
  • Stewart A. Factor
    ,
  • Mitchell Brin
    ,
  • Kapil D. Sethi
*Corresponding author for this work
  • Mayo Clinic Scottsdale, AZ
    ,
  • Albany Medical College
    ,
  • Icahn School of Medicine at Mount Sinai
    ,
  • Neurology
Scholary Output:
Contribution to journal
Article
 Peer-review

Abstract

Intramuscular injection of botulinum toxin type A is the treatment of choice for most cases of oromandibular dystonia. We report on five patients with oromandibular dystonia that developed secondary nonresponsiveness to botulinum toxin type A following multiple injections over a 6-year period.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
 Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 158-161 (4 pages)

Journal (Volume, Issue Number)

Movement Disorders (Volume 17, Issue 1)

Publication milestones

  • Published - 01/2002

Publication status

Published - 01/2002

ISSN

0885-3185

Publication IDs

  • Scopus: 0036461016
  • PubMed: 11835455

Access to documents

Publication metrics

Metrics

SciVal
FWCI
0.33
SciVal
Author count
4
SciVal
citations
10
SciVal
Paper percentile
58
Scopus
citations
15, opens in new tab
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
14
Citation count
17